SMTL ID : 6inl.1

Crystal structure of CDK2 IN complex with Inhibitor CVT-313

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.75 Å

Oligo State

monomer

Ligands

1 x AJR: 2,2'-{[6-{[(4-methoxyphenyl)methyl]amino}-9-(propan-2-yl)-9H-purin-2-yl]azanediyl}di(ethan-1-ol)(Non-covalent)

AJR.1: 18 residues within 4Å: Chain A: E.9, I.11, G.12, V.19, A.32, V.65, F.81, E.82, F.83, L.84, H.85, Q.86, D.87, Q.132, N.133, L.135, A.145, D.146 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:I.11, A:I.11, A:V.19, A:A.32, A:F.81, A:F.83, A:L.135, A:A.145 Hydrogen bonds: A:L.84, A:L.84, A:D.146 Water bridges: A:D.87, A:K.90

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Talapati, S.R. et al., Structure of cyclin-dependent kinase 2 (CDK2) in complex with the specific and potent inhibitor CVT-313. Acta Crystallogr.,Sect.F (2020)

Release Date

2019-10-30

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2

Related Entries With Identical Sequence